Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome
Tóm tắt
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by SFTS virus (SFTSV) with a high fatality rate. But the immunofunction was still unclear. The objective of our study was to assess the immunofunction in SFTS patients. Immunofunction test with flow cytometry which contains CD3+, CD4+ and CD8+ T lymphocytes, B cells and NK cells would be used for detecting serum samples collected from 34 SFTS cases and 20 healthy donors. We found that CD3+ and CD4+ T lymphocytes were significantly diminished in SFTS compared to normal control. In contrast, the percentage of NK cells was elevated. Further analysis revealed that the number of CD3+ and CD4+ T lymphocytes showed that there was a more robust pattern of depression in acute phase and severe SFTS infection compared to the patients in recovery phase and mild SFTS infection. But NK cells were significantly increased in acute phase and severe SFTS. They reverted to the near normal levels in convalescent phase. Additionally, the levels of CD3+ and CD4+ T lymphocytes progressively decreased in death group when compared with the survival group, but the level of B cells was higher. The damages of immune system were obvious, and the immune dysfunction might be partly responsible for disease progression of patients with SFTSV infection.
Tài liệu tham khảo
Liu Y, Li Q, Hu W, Wu J, Wang Y, Mei L et al (2012) Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis 12:156–160. doi:10.1089/vbz.2011.0758
Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK et al (2011) A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 53:1208–1214. doi:10.1093/cid/cir732
Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL et al (2011) Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 364:1523–1532. doi:10.1056/NEJMoa1010095
Zhang L, Liu Y, Ni D, Li Q, Yu Y, Yu XJ et al (2008) Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 300:2263–2270. doi:10.1001/jama.2008.626
Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41:61
Ergonul O (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203–214
Vinh DC, Embil JM (2009) Hantavirus pulmonary syndrome: a concise clinical review. South Med J 102:620–625. doi:10.1097/SMJ.0b013e3181a4eeda
Mackow ER, Gavrilovskaya IN (2009) Hantavirus regulation of endothelial cell functions. Thromb Haemost 102:1030–1041. doi:10.1160/TH09-09-0640
Frieman M, Heise M, Baric R (2008) SARS coronavirus and innate immunity. Virus Res 133:101–112
Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ et al (2012) Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis 54:527–533. doi:10.1093/cid/cir804
Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, 430 mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 431:17264–17269
Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG (2007) Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol 81:2554–2563
Sun Y, Liang M, Qu J, Jin C, Zhang Q, Li J et al (2012) Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay. J Clin Viral 53:48–53. doi:10.1016/j.jcv.2011.09.031
Jie SH, Zhou Y, Sun LP, Liang KW, Yi XL, Li HY (2013) Close correlation between development of MODS during the initial 72 h of hospitalization and hospital mortality in severe fever with thrombocytopenia syndrome. J Huazhong Univ Sci Technol 33:81–85. doi:10.1007/s11596-013-1075-1
Lee SH, Miyagi T, Biron CA (2007) Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 28:252–259
Maghazachi AA, Al-Aoukaty A (1998) Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J 12:913–924
Li T, Qiu Z, Han Y, Wang Z, Fan H, Lu W, et al (2003). Rapid loss of both CD4 + and CD8 + T lymphocyte subsets during the acute phase of severe acute respiratory syndrome. Chin Med J (Engl)116:985-987. PMID:12890367
Gao Y, Wang Y, He JR, Miu Q (2002) Study on subtype of T-lymphocyte in the critical cases with severe pneumonia. Ningxia Med J 24:331–332
Zeng R, Li C, Li N, Wei L, Cui Y (2011) The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma. Cytokine 53:1–7. doi:10.1016/j.cyto.2010.09.011
Deng B, Zhang S, Geng Y, Zhang Y, Wang Y, Yao W et al (2012) Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS ONE 7:e41365. doi:10.1371/journal.pone.0041365
Maghazachi AA (2010) Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341:37–58 (PMID:11818437)
Sobek V, Balkow S, Körner H, Simon MM (2002) Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur J Immunol 32:2490–2499 (PMID:12207333)